Novakand Pharma AB (publ) (LARK) — Financial Flexibility Index
Novakand Pharma AB (publ) (LARK) has a Financial Flexibility Index of -1.32x as of December 2025. Free cash flow of Skr-1.64 Million (operating CF Skr-1.64 Million minus capex Skr0.00) represents -1% of total liabilities (Skr1.24 Million). For the full cash flow conversion analysis, see Novakand Pharma AB (publ) (LARK) cash flow conversion.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Novakand Pharma AB (publ) Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Novakand Pharma AB (publ) across 14 annual periods. Check tangible equity quality of Novakand Pharma AB (publ) to evaluate the tangible quality of the company's equity base.
Annual Financial Flexibility Index for Novakand Pharma AB (publ) (2012–2025)
Year-by-year free cash flow to debt coverage for Novakand Pharma AB (publ). Check Novakand Pharma AB (publ) (LARK) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -10.31x | Skr-12.78 Million | Skr-12.78 Million | Skr1.24 Million | ▼ -48.1% |
| 2024 | -6.96x | Skr-29.95 Million | Skr-29.95 Million | Skr4.30 Million | ▲ +4.9% |
| 2023 | -7.33x | Skr-30.45 Million | Skr-30.56 Million | Skr4.16 Million | ▼ -168.1% |
| 2022 | -2.73x | Skr-16.67 Million | Skr-16.67 Million | Skr6.10 Million | ▼ -197.5% |
| 2021 | 2.80x | Skr22.26 Million | Skr22.11 Million | Skr7.94 Million | ▲ +158.5% |
| 2020 | -4.79x | Skr-38.24 Million | Skr-38.35 Million | Skr7.98 Million | ▼ -421.5% |
| 2019 | -0.92x | Skr-21.60 Million | Skr-21.60 Million | Skr23.51 Million | ▼ -2147.8% |
| 2018 | 0.04x | Skr657.80K | Skr227.60K | Skr14.66 Million | ▲ +100.8% |
| 2017 | -5.86x | Skr-9.53 Million | Skr-9.53 Million | Skr1.63 Million | ▲ +45.7% |
| 2016 | -10.78x | Skr-8.73 Million | Skr-8.81 Million | Skr809.66K | ▼ -24.6% |
| 2015 | -8.65x | Skr-5.99 Million | Skr-6.29 Million | Skr691.73K | ▼ -711.4% |
| 2014 | -1.07x | Skr-620.67K | Skr-620.67K | Skr582.04K | ▲ +83.9% |
| 2013 | -6.64x | Skr-272.15K | Skr-272.15K | Skr40.98K | ▼ -3426.4% |
| 2012 | 0.20x | Skr59.21K | Skr59.21K | Skr296.58K | — |